This inventor holds 1 USPTO granted patent. Top assignee: Joslin Diabetes Center, Inc.. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Jacalyn H Pierce: Innovator in Diabetes Research
Introduction
Jacalyn H Pierce is a prominent inventor based in Potomac, MD (US). She has made significant contributions to the field of diabetes research, particularly through her innovative work on insulin receptor substrates. Her dedication to advancing medical science has led to the development of valuable patents that aim to improve the understanding and treatment of diabetes.
Latest Patents
Jacalyn holds 1 patent related to her research. The patent is titled "DNA encoding an insulin receptor substrate." It encompasses a substantially pure nucleic acid comprising a sequence encoding an IRS-2 polypeptide, a substantially pure preparation of an IRS-2 polypeptide, and related methods. This invention is crucial for furthering the understanding of insulin signaling pathways and their implications in diabetes.
Career Highlights
Jacalyn is affiliated with the Joslin Diabetes Center, Inc., where she continues her research and development efforts. Her work at this esteemed institution has positioned her as a key figure in diabetes research, contributing to both academic knowledge and practical applications in the field.
Collaborations
Jacalyn has collaborated with notable colleagues, including Morris F White and Xiao Jian Sun. These partnerships have enhanced her research capabilities and broadened the impact of her work in the scientific community.
Conclusion
Jacalyn H Pierce is a dedicated inventor whose contributions to diabetes research are noteworthy. Her innovative patent on insulin receptor substrates exemplifies her commitment to advancing medical science. Through her work at the Joslin Diabetes Center, she continues to make strides in understanding diabetes and improving treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
